Intuitive Surgical (ISRG)
563.60
+0.00 (0.00%)
NASDAQ · Last Trade: May 19th, 4:27 AM EDT
Detailed Quote
Previous Close | 563.60 |
---|---|
Open | - |
Bid | 556.35 |
Ask | 559.90 |
Day's Range | N/A - N/A |
52 Week Range | 395.60 - 616.00 |
Volume | 848 |
Market Cap | 201.99B |
PE Ratio (TTM) | 82.52 |
EPS (TTM) | 6.8 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,785,342 |
Chart
About Intuitive Surgical (ISRG)
Intuitive Surgical is a pioneering medical device company specializing in robotic-assisted surgical systems, most notably the da Vinci Surgical System. This innovative platform enhances the precision and control of minimally invasive surgical procedures, enabling surgeons to perform operations with greater accuracy and reduced recovery times for patients. The company is dedicated to advancing the field of robotics in surgery, providing training and support for healthcare professionals, and continually innovating its technology to improve patient outcomes across various medical specialties. Read More
News & Press Releases
Intuitive Surgical Inc. (NASDAQ: ISRG) announces Dave Rosa as next CEO, effective July 1, 2025. Long-serving CEO Gary Guthart to become executive chair.
Via Benzinga · May 15, 2025
Gary Guthart will step down, effective July 1. He will be succeeded by Dave Rosa, the current president.
Via Investor's Business Daily · May 15, 2025
President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive’s boardCurrent Board Chair Craig Barratt to become lead independent director
By Intuitive Surgical, Inc. · Via GlobeNewswire · May 15, 2025
As the AI trade makes a comeback, these three ETFs provide niche opportunities for investors looking to capitalize on the continued growth in AI
Via MarketBeat · May 14, 2025
Via The Motley Fool · May 10, 2025
Via The Motley Fool · May 8, 2025
Via The Motley Fool · May 7, 2025
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
Via StockStory · May 7, 2025
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers.
Via StockStory · May 6, 2025
Via Benzinga · May 6, 2025
Via The Motley Fool · May 6, 2025
Via The Motley Fool · May 5, 2025
Now may be a smart time to buy small stakes in these fundamentally robust companies.
Via The Motley Fool · May 5, 2025
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold.
Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Via StockStory · May 5, 2025
Via The Motley Fool · May 3, 2025
Alphabet's ad business keeps putting up huge numbers, but a DOJ breakup, generative AI threats, and potential macro slowdown loom.
Via The Motley Fool · May 1, 2025
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP’s capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures - low anterior resection, total mesorectal excision, colectomy, abdominoperineal resection, and sigmoidectomy.
By Intuitive Surgical, Inc. · Via GlobeNewswire · May 1, 2025
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
Via Investor's Business Daily · May 1, 2025
Via The Motley Fool · May 1, 2025
Via The Motley Fool · April 26, 2025
Despite beating on the top and bottom lines, tariff uncertainty makes the outlook for ISRG stock fluid; investors may want to wait for clarity before jumping in
Via MarketBeat · April 25, 2025
Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new product cycle, and solid balance sheet.
Via Benzinga · April 23, 2025
Stocks are soaring this afternoon, with the Dow Jones Industrial Average up 871 points amid optimism over easing U.S.-China trade tensions.
Via Talk Markets · April 23, 2025